Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUOTECH: ICG Fluorescence vs Radioisotope for Sentinel Lymph Node Biopsy in Breast Cancer
NCT02279108Phase 3Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Nov 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indocyanine green in breast cancer, sponsored by CHU Saint-Etienne. Started Nov 2014; status: completed.
02
Drugs
indocyanine green
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02279108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279108.